---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-009713"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2023-04-07T23:59:59+00:00"
generated_at: "2026-06-17T04:50:22.166771+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Windtree pre-announces $4.2M cash at Q1 end; net cash used $2.9M in Q1

## Summary
- Cash and cash equivalents estimated at ~$4.2 million as of March 31, 2023.
- Net cash used before financing activities for Q1 2023 was $2.9 million.
- These are preliminary estimates; final Q1 results may differ materially.
- Company's cash burn rate raises potential going-concern risk for micro-cap biotech.

## SEC filing metadata
- accession: 0001437749-23-009713
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2023-04-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774923009713/0001437749-23-009713-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774923009713/wint20230406_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-009713
- JSON: https://secwatch.observer/filing/0001437749-23-009713.json
- Plain text: https://secwatch.observer/filing/0001437749-23-009713.txt

## Key facts
- Earnings Releases
  WINDTREE THERAPEUTICS INC /DE/ reported preliminary financial results for first quarter ended March 31, 2023.
  - Period: first quarter ended March 31, 2023
  - Result: preliminary results
  source text: Windtree Therapeutics, Inc. (the “Company”) is disclosing certain preliminary financial results for the first quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774923009713/0001437749-23-009713-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.